Non-HIV-related Kaposi's sarcoma suppressed by dapsone

British Journal of Dermatology

Volumn 135, Issue 5, 1996, Pages 813-814

  De Haas, E R M ^a   De Wit, R F E ^a   Van Vloten, W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE;

ADULT; AGED; ARTICLE; CASE REPORT; HUMAN; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL;

EID: 0029907682     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1996.d01-1087.x     Document Type: Article

References (8)

1. Epstein JB, Scully, C. HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 1991; 71: 38-41.
2. Friedman-Birnbaum R, Weltfriend S, Katz I. Kaposi's sarcoma: retrospective study of 67 cases with the classical form. Dermatologica 1990; 180: 13-17.
3. Poulsen A, Hultberg B, Thomson K, Wantzin GL. Regression of Kaposi's sarcoma in AIDS after treatment with dapsone. Lancet 1984; i (8576): 560.
4. Poulsen A, Hultberg B, Thomson K, Lange Wantzin GL. Dapsone in the treatment of Kaposi's sarcoma. Acta Derm Venerol (Stockh) 1984; 64: 561-3.
5. Hruza GJ, Friedman-Kien AE, Laubenstein LJ et al. Dapsone for AIDS-associated Kaposi's sarcoma. Lancet 1985; i (8429): 642.
6. Witte MH, Stuntz M, Witte CL. Kaposi's sarcoma. A lymphologic perspective. Int J Dermatol 1989; 28: 561-70.
7. Scott WP, Voight JA. Kaposi's sarcoma. Management with vincaleucoblastine. Cancer 1966; 19: 557-64.
8. Wozel G, Barth J. Current aspects of modes of action of Dapsone. Int Dermatol 1988; 27: 547-52.